Article Data

  • Views 1041
  • Dowloads 136

Original Research

Open Access

Twenty years of contributions to the study and prevention of uterine cancer

  • J.L. Garrido Martinez1,*,
  • M.M. Diaz1
  • A. Villarreal1

1National Association Against Cancer (ANCEC), Social Security Foundation (CSS), Chemsa Foundation, Panama City, Panama

DOI: 10.12892/ejgo200606600 Vol.27,Issue 6,November 2006 pp.600-602

Published: 10 November 2006

*Corresponding Author(s): J.L. Garrido Martinez E-mail:

Abstract

During 20 years of preventive study of the oncogenic risk of cervix-uterine cancer in the Republic of Panama, applying the protocol of the Gynecology Institute of the University of Padua, Italy, we diagnosed 5,009 cases out of the 9,312 patients studied. We classified them according to the degree of the pathology, guiding the patients to the appropriate treatment and the respective follow-up, and concluding that those women who do not follow recommendations have five times more probability of suffering from cervix-uterine cancer. Moreover, the age groups between 20 and 40 years old with HPV infection that do not have access to these procedures are highly vulnerable.

Keywords

Cervical uterine oncogenic risk; Diagnosis; Treatment evolution

Cite and Share

J.L. Garrido Martinez,M.M. Diaz,A. Villarreal. Twenty years of contributions to the study and prevention of uterine cancer. European Journal of Gynaecological Oncology. 2006. 27(6);600-602.

References

[1] Valdez P.: "Nine years of cancer in Panama". Rev. Medica de Panama, 1985, 10 (1), 23.

[2] Garrido J.L.: "Our experiences with colposcopy 1982-1989". International Meeting, ESGO, Barcelona, 1993.

[3] Onnis A.: "Clinical delle neoplasie genitali femmenili. II carcinoma della cervice uterina. Experienze cliniche nell'Istituto di Ginecologia e Ostetricia di Padova". Gin. Clin., 1991, 12, 163.

[4] Dexeus S.: "CIN treatment". Eur. J. Gynecol. Oncol., 1989, 10, 215.

[5] Garrido J.L.: "The O.R. evaluation in 15 years of study". ESGO, Venice, 2001.

[6] Garrido J.L.: "Evoluci6n de las pacientes con riesgo oncogenico tratadas, Panama 1982-1989". Arc. HST, 1993, 1, 29.

[7] Onnis A.: "II ruolo del ginecologo nella prevenzione, profilass1 e diagnosi precoce delle neoplasie ginecologiche". Gin. Clin., 1993, 14, 3.

[8] De Britton R.C.: "Virus and gynecological tumors in Latin America". Eur. J. Gynaecol. Oncol., 1991, 12, 7.

[9] Carta G.: "Colposcopy, cytology and histology in the diagnosis of squamous intraepithelial lesions of the cervix". Clin. Exp. Obstet. Gynecol., 1999, 26, 60.

[10] Pickel H., Winter R.: "Colposcopic小agnosis: Clinical aspects and experiences". Clin. Exp. Obstet. Gynecol., 1999, 26, 120.

[11] Marana H.R.C.: "Colposcopic scoring system for biopsy decisions in different groups". Eur. J. Gynecol. Oneal., 2000, 21, 368.

[12] Monsonego J.: "Cervical cancer screening and management, new challenges". Eur. J. Gynecol. Oneal., 1999, 20, 352.

[13] Garrido J.L.: "Human Pap仆Joma Virus - HPV Condylomata Current studies in diagnosis, treatment and prognosis". Clin. Exp Obstet. Gynecol., 1996, 99, 13.

[14] Anton C.: "The role of Colposcopy in the endemic increase of the cervical virosis - precursor of the cervical neoplasias". Eur. J. Gynecol. Oneal., 1999, 20 (suppl.), 26.

[15] De Palo G.: "The importance of colposcopy in the XXI century" Eur. J. Gynecol. Oneal., 2000, 21, 223.

Submission Turnaround Time

Top